P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
Financial Results:
Procter & Gamble Health Ltd reported Revenues for Q2FY24 of ₹305.00 Crores up from ₹298.00 Crore year on year, a rise of 2.35%.
Total Expenses for Q2FY24 of ₹222.00 Crores up from ₹214.00 Crores year on year, a rise of 3.74%.
Consolidated Net Profit of ₹66.00 Crores up 3.12% from ₹64.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹39.50, up 3.00% from ₹38.35 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.